The short answer
An increased stimulant effect from bitter orange plus dextromethorphan has not been established. Seville orange juice can alter dextromethorphan handling, but juice, extracts and multi-ingredient stimulants require separate assessment.
What this answer covers
Citrus aurantium juice, fruit extracts and mixed supplements; not grapefruit or purified synephrine as interchangeable exposures.
- Supplement or preparation
- Citrus aurantium
- Medication ingredient
- dextromethorphan
The direct study measured drug handling
A small study gave dextromethorphan with Seville orange juice and measured urinary drug and metabolites. The authors inferred altered bioavailability; they did not establish an increase in clinical stimulant effects.
A different preparation produced a different signal
A separate extract study found no significant change in several drug-metabolizing enzyme probes. Its preparation lacked one relevant citrus enzyme inhibitor. That result cannot cancel the juice finding or prove every extract safe.
Cardiovascular concerns need context
Bitter-orange safety reports often involve other ingredients, and studies of heart rate and blood pressure are inconsistent. Check whether a product also contains caffeine or other stimulants rather than attributing every effect to the botanical name.
Have the actual products reviewed
Show the pharmacist the cough formulation and supplement label before combining them. No protective spacing interval or predictable change in effect has been established. Follow the cough product’s own directions and seek care for concerning symptoms.
Evidence and practical considerations
Side effects & toxicity
Current claim asserts increased stimulant effects; direct juice study assessed pharmacokinetic inference, not that clinical endpoint. Extract probe null and mixed cardiovascular evidence prevent universal botanical claim.
- Exact scope
- Citrus aurantium juice, fruit extracts and mixed supplements; not grapefruit or purified synephrine as interchangeable exposures. with Dextromethorphan3289 IN; oral cough hydrobromide/polistirex formulations, not codeine or other pain opioids; psychiatric combinations explicitly limited.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No unmeasured pair incidence, blanket class transfer or arbitrary spacing interval.
Factors that may matter: Preparation; Dose; Other medicines; Organ function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed dextromethorphan
Cough suppressant with age-specific directions, overdose precautions and prohibition during prescription MAOI use or within2weeks after stopping that drug.
How this applies: Exact dextromethorphan RxCUI 3289 IN, with stated salt/formulation/route bridge.
Not a pain opioid label, not a sedating antihistamine combination, and MAOI interval cannot be assigned to every herb.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed dextromethorphan
Different age-specific schedule and release duration from caplets; MAOI prohibition and overdose precautions.
How this applies: Exact dextromethorphan RxCUI 3289 IN, with stated salt/formulation/route bridge.
Not interchangeable dosing with immediate-release products or psychiatric combinations containing a CYP2D6 inhibitor.
Source 3: national medication patient information
medlineplus.gov · Source check Sep 10, 2026
Population: People using dextromethorphan cough medicines
Possible dizziness and drowsiness; disclose supplements and other medicines; overdose can cause serious neurologic and breathing problems.
How this applies: Exact medication effects and review advice.
No exact supplement interaction incidence; overdose outcomes are not routine therapeutic-dose event rates.
Source 4: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 11 healthy volunteers.
Urinary parent/metabolite analysis was interpreted by authors as altered bioavailability with both juices and effects persisting through washout.
How this applies: Original abstract only; urinary pharmacokinetic inference, not a clinical stimulant endpoint or every bitter-orange extract. The unusual washout description cannot define a safe gap.
Original abstract only; urinary pharmacokinetic inference, not a clinical stimulant endpoint or every bitter-orange extract. The unusual washout description cannot define a safe gap.
Source 5: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 12 healthy volunteers.
No significant change in tested CYP phenotypes; preparation lacked6,7-dihydroxybergamottin.
How this applies: Not a dextromethorphan trial; metabolic null does not prove cardiovascular safety or equivalence to Seville orange juice.
Not a dextromethorphan trial; metabolic null does not prove cardiovascular safety or equivalence to Seville orange juice.
Source 6: federal supplement guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: Users of bitter-orange foods and supplements
Cardiovascular findings are inconsistent; serious reports often involve mixtures. Product amine content and adulteration vary.
How this applies: Preparation and endpoint uncertainty.
No exact dextromethorphan additive-stimulant trial; food amounts and extracts differ.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact dextromethorphan article with formulation-specific evidence and uncertainty. | |
| Research summary published |
Article revision: 3a52a7c2d62bb54e
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.